Physician profile
Danielle Pare
NPI 1629629324
$1,293.78
in general payments reported to CMS, 2019-2025
17 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $290 · 2022: $373 · 2023: $389 · 2024: $69.10 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.16 | 2021-2022 | |
| Indivior INC. | $213.17 | 2021-2023 | Sublocade |
| Astrazeneca Pharmaceuticals Lp | $187.44 | 2021-2025 | Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $160.60 | 2021-2023 | Rexulti |
| Alkermes, INC. | $74.74 | 2022-2023 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $45.71 | 2022 | |
| Collegium Pharmaceutical, INC. | $36.80 | 2025 | Jornay Pm |
| Exact Sciences Corporation | $34.21 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $31.24 | 2022-2023 | Gardasil 9, Vaxneuvance |
| Teva Pharmaceuticals USA, INC. | $30.56 | 2022-2023 | Austedo |
| Corium, LLC | $28.28 | 2023 | Azstarys |
| Lilly USA, LLC | $27.25 | 2025 | Zepbound, Mounjaro |
| Hologic Sales and Service, LLC | $20.80 | 2022 | |
| Glaxosmithkline, LLC. | $19.79 | 2023 | Trelegy Ellipta |
| Pfizer INC. | $17.96 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.57 | 2024 | |
| Phadia US INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Pare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.